Niiki Pharma to Present Phase I Clinical Data on Anti-Cancer Agent at American Society of Clinical Oncology
5/24/2012 9:28:54 AM
More...
|
Niiki Pharma Presents Data on NKP-2235, the First Highly Orally Bioavailable Gallium-Based Anti-Cancer Agent
4/3/2012 11:08:08 AM
More...
|
Niiki Pharma Forms Scientific Advisory Board with Leading U.S. Oncologists
2/1/2012 10:29:17 AM
More...
|
Niiki Pharma Announces the Completion of Phase I Dose Escalation for First-in-Man Anti-Cancer Agent NKP-1339
1/17/2012 10:22:28 AM
More...
|
Niiki Pharma Reports on Synergistic Activity of Novel Anti-Cancer Agent NKP-1339 with Other Anti-Cancer Agents
11/15/2011 10:55:52 AM
More...
|
Niiki Pharma Announces Positive Interim Data from Ongoing Clinical Trial of Novel Anti-Cancer Agent NKP-1339
9/20/2011 6:58:20 AM
More...
|